Skip to Main Content


Regulatory Oversight of Supplement Industry Continues

September 2017 - Nutrition Industry Executive
Social Logo Social Logo Social Logo

by Ronie Schmelz and Anne Cruz, published in Nutrition Industry Executive

The new administration has hardly hidden its disdain for regulation and disinterest in regulatory oversight. Nonetheless, year-to-date activity by federal regulators signals that agencies have no intention of letting up on their policing of the supplement industry. By mid-July 2017, the U.S. Food and Drug Administration (FDA) had issued nearly the same number of warning letters to supplement companies as it had for all of 2016. The warning letters cite numerous claim, labeling, branding and current good manufacturing practices (CGMP) violations.

Read the article here.

Perspectives on employee benefits, executive compensation and ERISA litigation to help you attract and retain talent.
lingua negoti
The language of business.
Ohio Environmental
Insights and commentary for the business and legal community.